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Abstract
Background and objectives: The Postoperative Nausea and Vomiting (PONV) Intensity Scale was 
developed to deﬁ ne clinically important PONV. The aim of this study was to translate, retranslate 
and validate the PONV Intensity Scale for use in Portuguese Post Anesthetic Care Unit (PACU) 
settings. 
Methods: The PONV Intensity Scale was translated and back-translated in accordance with 
available guidelines. The research team conducted an observational and cohort prospective study 
in a PACU. One-hundred ﬁ fty-seven adult patients admiited after surgery over three weeks were 
evaluated for PONV. Measurements included nausea visual analogic scale (VAS) at 6 and 24 hours, 
postoperatively. We assessed reliability and observer disagreement using interclass correlation 
(ICC) and Information-Based Measure of Disagreement (IBMD). We compared VAS scores between 
patients with clinically signiﬁ cant (≥50) and not signiﬁ cant (<50) PONV. 
Results: Thirty-nine patients (25%) had PONV at 6 hours and 54 (34%) had PONV at 24 hours. 
Thirty-six and 54 patients experienced nausea at 6 and 24 hours, respectively. Among patients 
with PONV, 6 patients (15%) and 9 patients (27%) had a clinically signiﬁ cant PONV intensity scale 
score at 6 and at 24 hours, respectively. The reliability was good both for PONV intensity scale 
score and for VAS and observer disagreement was slightly higher for VAS. The median nausea VAS 
scores were higher in patients with clinically signiﬁ cant PONV Intensity score. 
Conclusions: The PONV Intensity Scale appears to be an accurate and reliable assessment and 
monitoring instrument for PONV in the PACU settings.
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Introduction
The incidence of postoperative nausea and vomiting (PONV) 
is high, ranging between 20% and 30% after general anesthe-
sia 1-5. However, it can be as high as 70% in high-risk pa-
tients 6. PONV is associated with worst outcomes, increased 
costs and length of hospital stay 1,7. PONV is associated with 
higher rate of complications such as dehydration, electrolyte 
imbalance, suture dehiscence, bleeding, esophageal rupture 
and airway compromise 8,9.
PONV is reported as one of the most undesirable side ef-
fects after surgery, as studies that use the willingness-to-pay 
method to report this event have evaluated 10-13. 
Multiple risk factors for PONV related to the patient, the 
surgery or the anesthesia have been described in the litera-
ture 2. Apfel et al. 3 developed a risk score for PONV that has 
been used for prophylactic antiemetic therapy management. 
In this score, Apfel identiﬁ ed female gender, non-smokers, 
history of PONV and postoperative use of opioids as indepen-
dent risk factors of PONV. 
A scoring system allows us to estimate the risk of de-
veloping PONV 14,15. Nonetheless, accurately evaluating the 
occurrence of clinically important PONV is a more difﬁ cult 
task. Up to date, there is no standard method described in 
the literature. The VAS scale is a score from 0 to 100 mm 
that is often used to assess pain intensity in the postopera-
tive period 16; similarly, a VAS score can be used to evalu-
ate nausea. A VAS greater than 75 has been proposed as a 
screening tool for diagnosis of severe nausea 6.
Recently, Wengritzky et al. published a study in which 
they developed and tested a PONV Intensity Scale (Appendix 
1) 6 to assess clinically important PONV. A PONV Intensity 
Scale ≥ 50 deﬁ ned clinically important PONV and was as-
sociated with the need of antiemetic therapy, higher rates 
of complications and prolonged time of recovery.  This score 
was developed and tested in a general surgical population 
and performed well in the domains of validity, reliability 
and responsiveness 6.
The aim of this study is to translate, retranslate and 
validate the PONV Intensity Scale for use in clinical research 
and routine use in Portuguese speaking PACU settings. 
Methods
The institutional review board of Hospital de São João ap-
proved the study and each study patient provided informed 
consent preoperatively. This prospective study was carried 
out in the Post-Anesthesia Care Unit at the Hospital São 
João, a 1,100-bed community teaching hospital in Porto, 
Portugal. All adult post-operative patients admitted to the 
PACU who underwent scheduled or emergency non-cardiac 
and non-intracranial surgery between May 9th, 2011, and May 
31st, 2011, were eligible for the study. 
We excluded from the study patients who did not provide 
or were incapable of providing informed consent due to intel-
lectual or psychiatric disturbance that precluded complete 
cooperation, had a history of alcohol or drug dependence, 
were non-Portuguese speaking, showed distress or any severe 
pre-existing medical condition that limited objective assess-
ment after operation or had any life-threatening postopera-
tive complication.
Translation and back-translation of the PONV Intensity Scale. 
After permission from Wengritzky et al., translation of the 
instrument was done according to the guidelines suggested 
by The Translation and Cultural Adaptation group. This group 
has proposed guidelines and a model of principles for good 
practice in the translation process 17. 
The translation process is described as follows: prepara-
tion, forward translation, reconciliation, back translation, 
back translation review, harmonization, cognitive debrieﬁ ng, 
review of cognitive debrieﬁ ng results and ﬁ nalization and 
proofreading.
Preparation: We requested and received permission to use the 
PONV Intensity Scale instrument from its author-developer 
(Wengritzsky R.).
A group of experienced intensive care nurses, the author 
and a professional translator translated the source text of 
the English version of the PONV Intensity Scale to Portuguese. 
This was carried out independently at ﬁ rst, then, they met 
to compare their translations.
Reconciliation meant solving the discrepancies between 
original independent translations and sought agreement 
between individual preferences. 
The ﬁ nal Portuguese version was given to a professional 
translator for retranslation to English that did not see the 
original version. 
The group who had made the original translation com-
pared the retranslated version of the instruments to the 
original, identifying and correcting discrepancies.
The retranslated version was sent to Wengritzsky R. for 
approval and acceptance of the Portuguese version.
Ten experienced nurses specialized in intensive care were 
asked to read and examine the translated version to detect 
any unclear words, concepts or elements that they were un-
able to understand to ﬁ nalize the cognitive debrieﬁ ng.
The ﬁ ndings of the debrieﬁ ng process were incorporated 
to improve the translation’s efﬁ cacy. This involved the 
validation process, which tested the applicability of the 
Portuguese version of the PONV Intensity Scale used in a 
Portuguese PACU.
We obtained consent preoperatively from every patient. 
Anesthesia was conducted according to the attending an-
esthesiologist’s preference. Data collection occurred at 6 
and 24 hours, postoperatively. We recorded details of the 
anesthetic technique, including medications administered for 
PONV prophylaxis from the anesthetic record, and postopera-
tive opioid analgesics and antiemetics from the medication 
chart. We obtained the durations of surgery and anesthesia 
from the computerised theatre management system (PICIS). 
We considered surgery to be major if expected surgical 
time was >1 hour and minor if expected surgical time was 
<1 hour 18.
Data collected included gender, smoking status, history 
of PONV or motion sickness and preoperative antiemetic use. 
The Apfel simpliﬁ ed risk score was calculated. 
Patients were interviewed by one of the investigators at 
6 and at 24 hours postoperatively about vomiting, antiemetic 
medication or complications related to PONV. The PONV 
Intensity Scale (Appendix 2) and VAS scale for nausea were both 
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applied at this time. The PONV Intensity scale was developed 
to identify features of PONV that would describe its intensity 
and clinical importance. The key features of the scale include 
the intensity, pattern and duration of nausea. A score was 
calculated for each patient and a PONV Intensity Scale score 
of 50 was deﬁ ned as clinically signiﬁ cant PONV 6.
Patients were asked to score pain on a 10-point verbal nu-
merical rating scale and nausea on a 100 mm visual analogue 
scale (VAS). The limits of the nausea VAS were “no nausea” 
to “nausea as bad as it possibly could be”. A score greater 
than 70 mm was the cut-off for severe nausea.
Vomiting, which can be objectively measured, was re-
corded as the total number of patients who vomited and the 
number of vomits. 
Normally distributed data were summarised using mean and 
standard deviation and skewed data were summarised using 
median and interquartile range (IQR). 
In order to assess the reliability and observer disagree-
ment, diferent and independent observers to 24 patients 
applied the PONV intensity scale and VAS for nausea twice. 
We assessed reliability using Intraclass Correlation Coefﬁ cient 
(ICC) and observer disagreement using Information Based 
Measure of Disagreement (IBMD) 19, 20.
We compared VAS scores between patients with clinically 
signiﬁ cant (≥ 50) and not signiﬁ cant (< 50) PONV Intensity 
Scale using the Mann-Whitney U-test.  We compared the 
VAS (VAS score > 70 mm) for patients with severe nausea 
with severe nausea PONV Intensity Scale (PONV Intensity 
Scale ≥ 50).
Results
The Portuguese translation group met several times at 
weekly intervals to allow for reﬂ ection and a consensus 
was reached on the instrument’s contents and structure. 
The original authors of the PONV Intensity Scale, Wengritzky 
et al., accepted the Portuguese retranslated version of the 
scale. According to the team involved in the cognitive de-
brieﬁ ng and reading of the checklist, there were no unclear 
words that they were unable to understand. Thus, the PONV 
Intensity Scale was then evaluated in the described series of 
adult PACU patients.
After excluding 17 patients, we enrolled 157 patients in 
this study and completed data collection. The reasons for 
the exclusions were: 7 patients were admitted in a surgical 
intensive care unit, 3 patients were incapable of providing 
informed consent or had a mini-mental scale examination 
(MMSE) < 25, 3 patients were not submitted to surgery, 1 
patient was submitted to neurosurgical surgery, 1 was less 
than 18 years old, 1 did not speak Portuguese and 1 refused 
to participate. 
Table 1 – Type of surgery (n = 157).
General surgery n (%) 54 (34)
   Bariatric surgery n (%) 4 (3)
   Head and neck n (%) 14 (9)
   Breast surgery n (%) 5 (3)
   Laparoscopic surgery n (%) 13 (8)
   Laparotomy n (%) 18 (11)
Orthopedic n (%) 31 (20)
Urology n (%) 26 (17)
Gynecology n (%) 16 (10)
Vascular surgery n (%) 15 (10)
Plastic surgery n (%) 14 (9)
Otolaryngology n (%) 1 (1)
Table 2 - Description of the total numer of patients 
(n = 157).
Patient Characteristics
Age mean (SD) 55 (16) 
Male n (%) 74 (47)
Body Mass Index (kg.m-2) mean (SD) 27 (6)
ASA physical status ≥ III   n (%) 33 (21)
   RCRI >2 n (%) 11 (6)
Apfel risk factors n (%)
      Non-smokers 124 (79)
      Female 83 (53)
      Previous motion sickness 19 (21)
      Opioids 119 (76)
Apfel score n (%)
      0 or 1 32 (18)
      2 76 (43)
      3 or 4 69 (39)
Risk surgery n (%)
      Minor 26 (17)
      Major 131 (83)
Type of anesthesia n (%)
      General anesthesia 105 (67)
      Regional anesthesia 31 (20)
      Combined anesthesia 19 (12)
      Sedation/analgesia 2 (1)
Anesthetics n (%)
      Opioids 119 (76)
      NMB 102 (65)
Antiemetics n (%)
      Droperidol 11(7)
      Metoclopramide 107(68)
      Ondansetron 32(20)
      Dexametasona 44(28)
Nº of prophylactic antiemetics given n (%)
        0 37 (24)
        1 65 (41)
        2 36 (23)
        3 19 (12)
Duration of anesthesia (min) median (P25-
P75)
135 (90-200)
Duration surgery median (P25-P75) 90 (60-150)
Length of PACU stay (hours) median (P25-
P75)
100 (67-142)
Length of Hospital stay (days) median (P25-
P75)
5 (3-8)
RCRI: Revised Cardiac Risk Index; NMB: Neuro Muscular 
Blockers.
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The median time taken to complete the PONV Intensity 
Scale at the six-hour interview was one minute (the range 
was one to three minutes).
Table 1 describes the type of surgery for patients enrolled 
in the study. General surgery and orthopedics account for 
more than 50% of surgical procedures.
The characteristics of the total sample (n = 157) are 
described in Table 2. Thirty-nine patients (23%) had PONV 
at 6 hours and 54 (34%) had PONV at 24 hours (Table 3). 
Table 3 also describes the vomiting or retching and nausea 
experienced in the 157 patients enrolled in this study. Among 
patients with PONV, 6 patients (15%) and 9 patients (17%) 
had a clinically signiﬁ cant PONV intensity scale score at 6 
and at 24 hours, respectively (Table 4). Table 4 describes the 
remaining caracteristics of patients with PONV.
Different and independent observers applied the PONV 
intensity scale and VAS for nausea twice in 24 patients. 
The reliability was good for the PONV Intensity Scale, ICC = 
0.899 (95%CI 0.783-0.955) and for VAS, ICC = 0.977 (95%CI 
0.948-0.990). 
We found a higher observer disagreement for VAS than 
for PONV Intensity Scale, however without statistical sig-
niﬁ cance, IBMD = 0.064 (95%CI 0.000-0.162) vs IBMD = 0.116 
(95% CI 0.013-0.226).
The nausea VAS score among those with a clinically signiﬁ cant 
PONV Intensity Scale score at the six-hour interview (me-
dian = 75 mm; IQR: 50 to 83 mm) was higher than those with 
clinically not signiﬁ cant PONV according to PONV Intensity 
Scale, median = 30 mm; IQR: 10 to 50 mm (p = 0.009).
Considering severe nausea - a score of VAS greater than 
70 mm - there were 5 cases of severe nausea at the six-hour 
interview and 3 (60%) of those had clinically signiﬁ cant PONV 
Intensity Scale score. From the remaining 34 cases of nonse-
vere nausea (VAS ≤ 70 mm), 31 (91%) of those also had clinically 
not signiﬁ cant PONV according to PONV Intensity Scale.
The nausea VAS score among those with a clinically sig-
niﬁ cant PONV Intensity Scale score at the 24-hour interview, 
median = 70 mm; IQR: 55 to 80 mm, was also higher than 
those with clinically not signiﬁ cant PONV Intensity Scale, 
median = 30 mm; IQR: 10 to 50 mm (p = 0.001).
Considering severe nausea a score of VAS greater than 
70 mm, there were 7 cases of severe nausea at the 24-hour 
interview and 4 (57%) of those had clinically signiﬁ cant 
PONV Intensity Scale score. From the remaining 47 cases of 
nonsevere nausea (VAS ≤ 70 mm), 42 (89%) of those had also 
clinically not signiﬁ cant PONV according to PONV Intensity 
Scale.
Discussion
This study suggests that the Portuguese PONV Intensity Scale 
is a reliable and valid tool in detecting postoperative nausea 
and vomiting in patients. In this study, we followed the guide-
lines for translation and cultural adaptation of the ISPOR TCA 
task force 17.The translated PONV Intensity Scale underwent 
a full validation process prior to its use, according to the TCA 
task force’s recommendations 17. A group of researchers and 
professional translators translated the PONV Intensity Scale, 
preserving the meaning of twords and concepts speciﬁ c to the 
postoperative context. All the investigators were enrolled in 
the processes of planning, baseline, and education phases. 
In our study, the physicians observed all the patients and 
recorded the data collected at 6 and 24 hours. The reliability 
coefﬁ cient achieved for PONV Intensity Scale and Nausea VAS 
scale was excellent, indicating that this scale is a reliable 
instrument to identify signiﬁ cant PONV. In addition to its 
reliability, the study demonstrated that physicians can easily 
learn and apply the Portuguese version of the PONV Intensity 
Scale in their daily clinical practice.
The correlation of the PONV Intensity Scale score with 
the nausea VAS at the sixth and the 24th hour interviews 
supported its validity, indicating that a higher score was 
associated with a greater postoperative nausea experience. 
A clinically important PONV Intensity Scale score was also 
signiﬁ cantly related to the incidence of vomiting at the 
Table 3 - Postoperative Nausea and Vomiting (PONV) 
evaluation at 6th- and 24th-hour evaluation in the 157 
patients.
Evaluation at:
6h 24h
n (%) n (%)
NVPO 39 (23) 54 (34)
Vomiting or retching 19 (12) 30 (19)
Nausea experienced 36 (25) 54 (34)
Table 4 - Description of patients with Postoperative 
Nausea and Vomiting (PONV).
PONV
at 6 hours at 24 hours
n = 39 n = 54
Actively treated, n (%) 19 (53) 24 (44)
Nausea pattern, n (%)
   Varying 37 (95) 53(98)
   Constant 2 (5) 1(2)
Nausea pattern description n 
(%)
   Sometimes 19 (57) 30 (56)
   Often or most of the time 14 (33) 19 (35)
   All the time 3(10) 5 (9)
Duration of nausea, n (%)
   Varying 69 (72) 74 (76)
   Constant 55 (53) 55 (53)
Number of vomits n
   0
   1-2 12 21
   3-4 3 5
Dry-retching n 4 4
VAS >70 n (%) 5 (13) 7 (13)
VAS, m median (P25-P75) 4 (2-6) 5 (1-5)
PONV Intensity scale ≥50 n (%) 6 (15) 9 (17)
PONV Intensity scale median 
(P25-P75)
2 (0.6-25) 4 (1-25)
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six-hour and 24-hour time points, which supports vomiting 
occurrence being associated with a greater experience of 
PONV and, thus, validates the scale. 
Clinically important PONV - deﬁ ned by a PONV Intensity 
Scale score of 50 - was recorded in 54 patients (34%) in the 
ﬁ rst 24 hours postoperatively, which is similar to the rate 
of clinically important PONV reported in a general surgical 
population by the developers of the PONV Intensity Scale 6. 
Nausea of some form was reported in 54 patients (34%) 
and vomiting or retching was experienced by 19%, which is 
consistent with the high Apfel scores recorded (3 or 4 risk 
factors in 39%). Therefore, clinically important PONV was less 
common than any PONV symptom in this study, which is to be 
expected if the PONV Intensity Scale is able to discriminate 
between trivial and clinically important PONV.
In spite of the high incidence of patients with Apfel score 
3 or 4, only 35% patients received double or triple anti-emetic 
therapy. This can be explained by a lack of preoperative 
identiﬁ cation of risk factors or the anesthesiologist’s valu-
ing of PONV 21.
This study has several limitations. The time period of 
assessment was limited to 24 hours; therefore, we may have 
missed patients presenting late PONV. The sample size also 
limited the value of our PONV risk assessment results and 
prophylaxis guidelines compliance.
In summary, the Portuguese version of the PONV Intensity 
Scale showed a good correlation with the original version. 
The PONV Intensity Scale appears to be an accurate and 
reliable assessment and monitoring instrument for PONV in 
the PACU settings.
Appendix 1 – The Postoperative Nausea and Vomiting Intensity scale.
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Anexo 2 – Escala de intensidade de Náuseas e Vômitos Pós-Operatórios (Portuguese version).
Questionário Pontuação
A) 6 horas após a cirurgia (ou na hora da alta, em caso de cirurgia ambulatorial)
Q1) Vomitou ou teve esforço de vômito não produtivo?
a) Não
b) 1 ou 2 vezes
c) 3 ou mais vezes
0
2
50
Q2) Sentiu náuseas (“uma indisposição gástrica e ligeira vontade de vomitar”)? Se a resposta for sim, a sensação de náusea 
interferiu em suas atividades cotidianas, como levantar-se da cama, movimentar-se sem restrições na cama, caminhar 
normalmente ou comer e beber?
a) Não
b) Às vezes
c) Frequentemente ou a maior parte do tempo
d) Sempre
0
1
2
25
Q3) Os episódios de náusea foram predominantemente:
a) intermitentes (“surgem e desaparecem”)?
b) constantes (“sempre ou quase sempre presentes”)?
1
2
Q4) Qual foi a duração do episódio de náuseas?
(em horas ou fração de horas)
__:__ horas
Para a parte A se a resposta a Q1 = c) pontuação A = 50; de outro modo, selecione a 
pontuação mais elevada de Q1 ou Q2 e multiplique X Q3xQ4
Pontuação de Intensidade de NVPO = 
___________
Para a parte A se Q1= c então A = 50
De outro modo, selecione a pontuação mais elevada de Q1 ou Q2 e multiplique por 
Q3xQ4
NVPO = ___________
*Registre a ocorrência de episódios distintos: a ocorrência de vários episódios de vômito ou ânsia de vômito não produtivo 
durante um pequeno período de tempo; por exemplo, cinco minutos devem ser registrados como um episódio; episódios 
múltiplos devem ser considerados se intervalados por períodos sem vômitos/ânsia de vômito não produtivo. 
Pontuação para a importância clínica dos NVPO
Pontuação
NVPO clinicamente importantes são deﬁ nidos como uma pontuação ≥ 50 em qualquer 
período do estudo. As pontuações obtidas em 6 e 24 horas (e em  72 horas, se consideradas 
importantes no contexto clínico) podem ser somadas para quantiﬁ cação do período total ou 
podem ser subescalas usadas para cada período.
Pontuação ﬁ nal da escala de 
intensidade de NVPO (0-72h)
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